MétaCan
Menu
Back to cohort
Record W4417010346 · doi:10.1182/blood-2025-944

The ASH consa consortium on newborn screening in Africa for sickle cell disease: Interim updates of progress in screening, follow-up and supporting initiatives

2025· article· en· W4417010346 on OpenAlexaff
Obiageli Nnodu, Bernard Awuonda, Lulu Chirande, Charles Kiyaga, Catherine I. Segbefia, Catherine Chunda‐Liyoka, Patience Camille Franklin, Andrew Zapfel, Marie Benoit, Alexis A. Thompson, Venée N. Tubman, Isaac Odame, Maureen Achebe, Nancy Berliner, Thérèsa L. Coetzer, Russell E. Ware, Enrico M. Novelli, Nancy Green

Bibliographic record

VenueBlood · 2025
Typearticle
Languageen
FieldMedicine
TopicHemoglobinopathies and Related Disorders
Canadian institutionsHospital for Sick Children
Fundersnot available
KeywordsNewborn screeningInterimInterim analysisIncidence (geometry)Intervention (counseling)Health careSickle cell anemiaDiseaseClinical trial

Abstract

fetched live from OpenAlex

Abstract Introduction: Children born with sickle cell disease (SCD) in sub-Saharan Africa (SSA) are at >50% risk for under age 5 mortality (U5M). To demonstrate whether newborn SCD screening in SSA and early entry into standard care will lower rates of U5M, the American Society of Hematology (ASH) established the Consortium on Newborn Screening in Africa (CONSA) in 10 sites in 7 countries: Ghana, Kenya, Liberia, Nigeria, Tanzania, Uganda and Zambia. The hypothesis is that early infant SCD screening and entry into standard continuous care will reduce U5M compared to historical estimates.Primary objectives are to determine: a) the population-based birth incidence of SCD; and b) effectiveness of early standardized care for preventing U5M consortium-wide at each country's site(s).Secondary objectives are to: a) establish SCD newborn screening programs and early intervention programs; and b) assess implementation and sustainability. Methods: CONSA is a multi-country health intervention program for centralized in-country newborn screening for SCD laboratory analysis of dried bloodspots, with enrollment of infants with SCD into early, continuous standardized care. Additional program needs have been identified, described here. Results: This report presents interim data on screening and clinical follow-up, highlighting several key initiatives developed to strengthen the CONSA program, which was launched in 2020. To date, results from 158,736 screened babies revealed 2201 (1.39%), with SCD, 25708 (16.20%) with S and 2531 (1.59%) C trait, and 1814 (1.14%) with another variant. Of those with screening results indicative of SCD, 693 underwent confirmatory testing, which established the diagnosis in 624 individuals (90%). To date, 847 (38.5%) have had an initial documented SCD clinical visit at a CONSA site. Others are receiving care at non-CONSA sites. Several initiatives are supporting CONSA, some through external resources:Screening and diagnostic capacity: Collaboration with a global technical source and in-country distributors has established networks to procure and distribute laboratory supplies, and provides technical support for laboratory guidance, training and troubleshooting to enhance laboratory capacity on isoelectric focusing using dried bloodspots and interpreting results.Sites were provided with supplies of the HemotypeSC device for rapid point-of-care diagnostic confirmation.Digital Health: A CONSA mobile phone app was created to support digital data collection with delayed cloud upload to the central database. Text messages are sent to families of infants with results of non-abnormal hemoglobin, reducing notification workload for data managers and nursing staff.Text messages are sent to affected families to remind them of follow-up visits.Health Education Initiative: Training with doctors, nurses, community health workers (CHWs), and other allied health professionals on SCD diagnosis and care has created networks of healthcare professionals for children living with SCD.More than 1,800 healthcare providers have been trained, with substantial pre- vs. post-test improvement.Improving clinical follow-up and retention in care: CONSA sites are partnering with local pediatric clinics to provide care, with referral to secondary or tertiary care as needed.The new CHW Initiative aims to support families of affected infants to increase documented visits for confirmatory diagnosis, enrollment and retention in care.Enhancing access to hydroxyureaSustainability: Measures to increase public awareness and reduce the stigma of SCD are underway to enhance in-country advocacy. CONSA country leaders are supported in developing key messages and strategies to engage local and national government leadership to promote their SCD efforts.Small grants are being provided through contracts with local community-based organizations to support community engagement and SCD advocacy at CONSA sitesSocial media outreach on SCD is being piloted to improve public awareness, specifically through promotional videos developed by musical artists collaborating with health education groups, distributed via popular global apps generally aimed at adolescents and young adults. Conclusions: Newborn screening encompasses a program beyond a test. Much progress has been made by the CONSA program that is tailored to local SSA strengths. The program is supported by several key initiatives to ensure effectiveness and sustainability.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.079
metaresearch head score (Gemma)0.058
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.079
Threshold uncertainty score0.418

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0790.058
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0060.004
Science and technology studies0.0020.001
Scholarly communication0.0040.002
Open science0.0040.006
Research integrity0.0020.003
Insufficient payload (model declined to judge)0.0090.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.287
Teacher spread0.271 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueBloodSame topicHemoglobinopathies and Related DisordersFrench-language works237,207